Search

Displaying 1 - 4 of 4 items.

Golden Rice

Golden Rice was engineered from normal rice by Ingo Potrykus and Peter Beyer in the 1990s to help improve human health. Golden Rice has an engineered multi-gene biochemical pathway in its genome. This pathway produces beta-carotene, a molecule that becomes vitamin A when metabolized by humans. Ingo Potrykus worked at the Swiss Federal Institute of Technology in Zurich, Switzerland, and Peter Beyer worked at University of Freiburg, in Freiburg, Germany. The US Rockefeller Foundation supported their collaboration.

Format: Articles

Subject: Organisms, Legal

Intraspecies Chimeras Produced in Laboratory Settings (1960-1975)

When cells-but not DNA-from two or more genetically distinct individuals combine to form a new individual, the result is called a chimera. Though chimeras occasionally occur in nature, scientists have produced chimeras in a laboratory setting since the 1960s. During the creation of a chimera, the DNA molecules do not exchange genetic material (recombine), unlike in sexual reproduction or in hybrid organisms, which result from genetic material exchanged between two different species. A chimera instead contains discrete cell populations with two unique sets of parental genes.

Format: Articles

Subject: Organisms, Processes

Oviraptor philoceratops Dinosaurs

Oviraptor philoceratops was a small bird-like dinosaur that lived about seventy-five million years ago, during the late Cretaceous period. In 1923, George Olsen of the American Museum of Natural History (AMNH) in New York City, New York, discovered the first Oviraptor fossilized skeleton on top of a dinosaur egg nest in the Gobi Desert, Mongolia. Because of the close proximity of dinosaur and nest, when Henry Fairfield Osborn president of the AMNH published on the discovery, he assumed that the Oviraptor had died attempting to steal the eggs.

Format: Articles

Subject: Organisms

Studies of Thalidomide's Effects on Rodent Embryos from 1962-2008

Thalidomide is a sedative drug introduced to European markets on 1 October 1957 after extensive testing on rodent embryos to ensure its safety. Early laboratory tests in rodent populations showed that pregnant rodents could safely use it, so doctors prescribed Thalidomide to treat morning sickness in pregnant women. However, in humans Thalidomide interfered with embryonic and fetal development in ways not observed in rodent tests.

Format: Articles

Subject: Organisms, Reproduction, Disorders